These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24879938)

  • 1. Heat induced evaporative antisolvent nanoprecipitation (HIEAN) of itraconazole.
    Mugheirbi NA; Paluch KJ; Tajber L
    Int J Pharm; 2014 Aug; 471(1-2):400-11. PubMed ID: 24879938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesophase and size manipulation of itraconazole liquid crystalline nanoparticles produced via quasi nanoemulsion precipitation.
    Mugheirbi NA; Tajber L
    Eur J Pharm Biopharm; 2015 Oct; 96():226-36. PubMed ID: 26264714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of polyethylene glycol polymers on the physicochemical properties and mucoadhesivity of itraconazole nanoparticles.
    Machado Cruz R; Santos-Martinez MJ; Tajber L
    Eur J Pharm Biopharm; 2019 Nov; 144():57-67. PubMed ID: 31493509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ monitoring of nanoparticle formation: Antisolvent precipitation of azole anti-fungal drugs.
    McComiskey KPM; Mugheirbi NA; Stapleton J; Tajber L
    Int J Pharm; 2018 May; 543(1-2):201-213. PubMed ID: 29604371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole-loaded micelles based on linear-dendritic poly (ethylene glycol)-b-poly (ε-caprolactone).
    Li S; Wei W; Jia W; Zhao L; Xu H; Zhou F; Zhu L; Song Z; Feng S; Feng R
    J Biomater Sci Polym Ed; 2018 Dec; 29(18):2299-2311. PubMed ID: 30485754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lubricant-Induced Crystallization of Itraconazole From Tablets Made of Electrospun Amorphous Solid Dispersion.
    Démuth B; Farkas A; Balogh A; Bartosiewicz K; Kállai-Szabó B; Bertels J; Vigh T; Mensch J; Verreck G; Van Assche I; Marosi G; Nagy ZK
    J Pharm Sci; 2016 Sep; 105(9):2982-2988. PubMed ID: 27290626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability.
    Miller MA; DiNunzio J; Matteucci ME; Ludher BS; Williams RO; Johnston KP
    Drug Dev Ind Pharm; 2012 May; 38(5):557-70. PubMed ID: 21961961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation.
    Zu Y; Sun W; Zhao X; Wang W; Li Y; Ge Y; Liu Y; Wang K
    Eur J Pharm Sci; 2014 Mar; 53():109-17. PubMed ID: 24345795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies.
    Alhowyan AA; Altamimi MA; Kalam MA; Khan AA; Badran M; Binkhathlan Z; Alkholief M; Alshamsan A
    J Microbiol Methods; 2019 Jun; 161():87-95. PubMed ID: 30738109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly supersaturated solutions from dissolution of amorphous itraconazole microparticles at pH 6.8.
    Matteucci ME; Paguio JC; Miller MA; Williams RO; Johnston KP
    Mol Pharm; 2009; 6(2):375-85. PubMed ID: 19236040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability.
    Fadke J; Desai J; Thakkar H
    AAPS PharmSciTech; 2015 Dec; 16(6):1434-44. PubMed ID: 25991065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol/hydroxypropylmethylcellulose 2910 E5 blends.
    Janssens S; Denivelle S; Rombaut P; Van den Mooter G
    Eur J Pharm Sci; 2008 Oct; 35(3):203-10. PubMed ID: 18656535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of particle size methodology and assessment of nanoparticle tracking analysis (NTA) as a tool for live monitoring of crystallisation pathways.
    McComiskey KPM; Tajber L
    Eur J Pharm Biopharm; 2018 Sep; 130():314-326. PubMed ID: 30012404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt.
    Kumar N; Shishu ; Bansal G; Kumar S; Jana AK
    Drug Dev Ind Pharm; 2013 Feb; 39(2):342-51. PubMed ID: 22553909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
    Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
    Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.